Bharat Parenterals Ltd Valuation
BPLPHARMA · Healthcare · Current price ₹1,436.4
Is Bharat Parenterals Ltd undervalued?
DocStoX estimates the fair value of Bharat Parenterals Ltd at ₹383 per share, versus the current market price of ₹1,436. That puts the stock about -73.3% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is medium.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹324), Relative P/E (₹498), Graham floor (₹388). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹324 (bear) to ₹383 (base) to ₹498 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Valuation multiples
Bharat Parenterals Ltd trades at a P/E of — and a P/B of 3.2x, with a dividend yield of 0.1%. Multiples are most useful compared against the company's own history and its sector peers — see the peer comparison for context.
Understand the ratios
More on Bharat Parenterals Ltd
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.